← Back to Search

Implantable Device

Implantable Defibrillator for Heart Attack (REFINE-ICD Trial)

Phase 3
Recruiting
Led By Derek V Exner, MD, MPH
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up average follow-up 5 years.
Awards & highlights

Summary

This trial will test whether an implantable defibrillator can help people who have had a heart attack in the last five years, have abnormal test results from a 24-hour heart monitor, and have low normal heart function.

Who is the study for?
This trial is for people who've had a heart attack, show abnormal results from a day-long heart monitor test, and have low but normal heart function. The specific eligibility will be determined by the site investigators.
What is being tested?
The study is testing if an implantable defibrillator can help patients live longer after having a heart attack compared to usual care without the device.
What are the potential side effects?
Potential side effects may include discomfort or infection at the implant site, inappropriate shocks from the device, or complications related to device maintenance.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~average follow-up 5 years.
This trial's timeline: 3 weeks for screening, Varies for treatment, and average follow-up 5 years. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mortality
Secondary study objectives
Appropriate ICD therapies
Arrhythmic death
Arrhythmic syncope
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Implantable Cardioverter Defibrillator + Usual CareExperimental Treatment1 Intervention
Medtronic ICD
Group II: Usual CareActive Control1 Intervention
Usual post-MI care

Find a Location

Who is running the clinical trial?

Cardiac Arrhythmia Network of CanadaOTHER
11 Previous Clinical Trials
6,969 Total Patients Enrolled
Accelerating Clinical Trials ConsortiumUNKNOWN
University of CalgaryLead Sponsor
800 Previous Clinical Trials
874,470 Total Patients Enrolled
~13 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top